Q2 2015 13F Holders as of 6/30/2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
62.5M
-
Number of holders
-
68
-
Total 13F shares, excl. options
-
23.1M
-
Shares change
-
+22.2M
-
Total reported value, excl. options
-
$610M
-
Value change
-
+$586M
-
Number of buys
-
66
-
Price
-
$26.49
Significant Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q2 2015
68 filings reported holding BPMC - Blueprint Medicines Corp - Common Stock, par value $0.001 per share as of Q2 2015.
Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23.1M shares
of 62.5M outstanding shares and own 37.02% of the company stock.
Largest 10 shareholders include Third Rock Ventures, LLC (7.39M shares), FMR LLC (4.07M shares), BVF INC/IL (1.58M shares), WELLINGTON MANAGEMENT GROUP LLP (1.14M shares), Visium Asset Management, LP (945K shares), RA CAPITAL MANAGEMENT, LLC (878K shares), Partner Fund Management, L.P. (862K shares), LORD, ABBETT & CO. LLC (735K shares), Citadel Advisors LLC (684K shares), and DRIEHAUS CAPITAL MANAGEMENT LLC (508K shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.